← Leaderboards
Peter G Schultz
University Of California San Francisco
$24,113,739
Attributed
$25,741,939
Total exposure
17
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,741,939 · 17
By mechanism
R01$19,133,037 · 9
R35$2,695,714 · 1
RC2$2,536,301 · 1
RC1$1,000,000 · 1
P01$324,390 · 1
P41$52,497 · 4
Top collaborators
- Kevin P. Campbell2 shared
- Vaughn Vasil Smider2 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Thomas Sterling Scanlan$10,376,751
- Herschel V Wade$273,775
- Carl V Hanson$1,184,549
- Reese T. Jones$7,250,168
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsBiologicalAmino AcidsGenerationsIn VivoPropertyGenetic CodeIn VitroProtein Structure FunctionEvolutionTransfer RnaTechnologyOrganismAffinityProtein FunctionProtein StructureBaseCellsSpecificityInsightPeptidesCodon NucleotidesMutationMammalian Cell
Grant awards (67)
Synthesis at the Interface of Chemistry and Biology$732,320
R35 · FY2025 · GM · contact PI
Synthesis at the Interface of Chemistry and Biology$732,320
R35 · FY2024 · GM · contact PI
Synthesis at the Interface of Chemistry and Biology$31,297
R35 · FY2024 · GM · contact PI
Synthesis at the Interface of Chemistry and Biology$720,380
R35 · FY2023 · GM · contact PI
In Vivo Incorporation of Unnatural Amino Acids$498,263
R01 · FY2022 · GM · contact PI
Synthesis at the Interface of Chemistry and Biology$479,397
R35 · FY2022 · GM · contact PI
In Vivo Incorporation of Unnatural Amino Acids$498,263
R01 · FY2021 · GM · contact PI
Experimentally Testing the Endosymbiotic Theory of Mitochondrial Evolution$377,325
R01 · FY2021 · GM · contact PI
In Vivo Incorporation of Unnatural Amino Acids$498,263
R01 · FY2020 · GM · contact PI
Experimentally Testing the Endosymbiotic Theory of Mitochondrial Evolution$377,325
R01 · FY2020 · GM · contact PI
In Vivo Incorporation of Unnatural Amino Acids$498,263
R01 · FY2019 · GM · contact PI
Experimentally Testing the Endosymbiotic Theory of Mitochondrial Evolution$377,325
R01 · FY2019 · GM · contact PI
An Orally Bioavailable Drug Candidate for Spinal Muscular Atrophy$488,276
R01 · FY2017 · NS · contact PI
In Vivo Incorporation of Unnatural Amino Acids$481,250
R01 · FY2017 · GM · contact PI
In Vivo Incorporation of Unnatural Amino Acids$473,750
R01 · FY2016 · GM · contact PI
An Orally Bioavailable Drug Candidate for Spinal Muscular Atrophy$381,899
R01 · FY2016 · NS · contact PI
In Vivo Incorporation of Unnatural Amino Acids$473,750
R01 · FY2015 · GM · contact PI
Molecular and Structural Studies of Antibody Diversity Mechanisms$360,050
R01 · FY2015 · GM
In Vivo Incorporation of Unnatural Amino Acids$473,750
R01 · FY2014 · GM · contact PI
Molecular and Structural Studies of Antibody Diversity Mechanisms$360,050
R01 · FY2014 · GM
Ribosomal Synthesis of Peptides with Unnatural Building Blocks$355,881
R01 · FY2014 · GM · contact PI
Ribosomal Synthesis of Peptides with Unnatural Building Blocks$343,425
R01 · FY2013 · GM · contact PI
In Vivo Incorporation of Unnatural Amino Acids$445,749
R01 · FY2012 · GM · contact PI
Ribosomal Synthesis of Peptides with Unnatural Building Blocks$355,881
R01 · FY2012 · GM · contact PI
In Vivo Incorporation of Unnatural Amino Acids$445,749
R01 · FY2011 · GM · contact PI
Ribosomal Synthesis of Peptides with Unnatural Building Blocks$355,881
R01 · FY2011 · GM · contact PI
STOP CODON PROJECT$12,768
P41 · FY2011 · RR · contact PI
High-throughput genetic & small-molecule screening for therapeutic modifiers$910,336
RC2 · FY2010 · NS
Delineating factors to control differentiation of skin derived precursor cells$500,000
RC1 · FY2010 · AR · contact PI
In Vivo Incorporation of Unnatural Amino Acids$450,252
R01 · FY2010 · GM · contact PI
Synthesis of Catalytic Antibodies$422,111
R01 · FY2010 · GM · contact PI
PROTEIN ANALYSIS$2,425
P41 · FY2010 · RR · contact PI
High-throughput genetic & small-molecule screening for therapeutic modifiers$1,625,965
RC2 · FY2009 · NS
Delineating factors to control differentiation of skin derived precursor cells$500,000
RC1 · FY2009 · AR · contact PI
In Vivo Incorporation of Unnatural Amino Acids$454,800
R01 · FY2009 · GM · contact PI
Synthesis of Catalytic Antibodies$426,375
R01 · FY2009 · GM · contact PI
In vivo Incorporation of Unnatural Amino Acids$437,049
R01 · FY2008 · GM · contact PI
Synthesis of Catalytic Antibodies$426,375
R01 · FY2008 · GM · contact PI
Synthesis of Catalytic Antibodies$419,400
R01 · FY2007 · GM · contact PI
In vivo Incorporation of Unnatural Amino Acids$352,534
R01 · FY2007 · GM · contact PI
In vivo Incorporation of Unnatural Amino Acids$25,472
R01 · FY2007 · GM · contact PI
Synthesis of Catalytic Antibodies$403,236
R01 · FY2006 · GM · contact PI
In vivo Incorporation of Unnatural Amino Acids$363,063
R01 · FY2006 · GM · contact PI
GENETIC MISREGULATION AND HUMAN CARTILAGE AGING$164,592
P01 · FY2006 · AG · contact PI
Synthesis of Catalytic Antibodies$412,940
R01 · FY2005 · GM
In vivo Incorporation of Unnatural Amino Acids$371,800
R01 · FY2005 · GM
Nucleic Acids with Novel Structures and Functions$334,286
R01 · FY2005 · GM
Synthesis of Catalytic Antibodies$412,940
R01 · FY2004 · GM
Nucleic Acids with Novel Structures and Functions$351,880
R01 · FY2004 · GM
Single Molecule Studies of Biomolecules$296,320
R01 · FY2004 · GM
Synthesis of Catalytic Antibodies$412,940
R01 · FY2003 · GM
Nucleic Acids with Novel Structures and Functions$351,880
R01 · FY2003 · GM
IN VIVO INCORPORATION OF UNNATURAL AMINO ACIDS$318,544
R01 · FY2003 · GM
Single Molecule Studies of Biomolecules$296,320
R01 · FY2003 · GM
Nucleic Acids with Novel Structures and Functions$369,474
R01 · FY2002 · GM
IN VIVO INCORPORATION OF UNNATURAL AMINO ACIDS$318,544
R01 · FY2002 · GM
Single Molecule Studies of Biomolecules$296,320
R01 · FY2002 · GM
GENETIC MISREGULATION AND HUMAN CARTILAGE AGING$159,798
P01 · FY2002 · AG
PROTEIN STUDIES W/ UNNATURAL AMINO ACIDS$0
P41 · FY2002 · RR
Single Molecule Studies of Biomolecules$329,864
R01 · FY2001 · GM
SYNTHESIS OF CATALYLIC ANTIBODIES$319,702
R01 · FY2001 · GM
IN VIVO INCORPORATION OF UNNATURAL AMINO ACIDS$294,318
R01 · FY2001 · GM
PROTEIN STUDIES W/ UNNATURAL AMINO ACIDS$0
P41 · FY2001 · RR
SYNTHESIS OF CATALYLIC ANTIBODIES$313,495
R01 · FY2000 · GM
PROTEIN STUDIES WITH UNNATURAL AMINO ACIDS$230,435
R01 · FY2000 · GM
EXAM OF RIBONUCLEOTIDE REDUCTASE USING UNNATURAL AMINO ACID MUTAGENESIS$27,424
P41 · FY2000 · RR
PROTEIN STUDIES W/ UNNATURAL AMINO ACIDS$9,880
P41 · FY2000 · RR